Cannabigerol, also known as  CBG is a non-psychoactive cannabinoid, meaning it doesn’t produce the “highs” that are synonymous with THC. Because it is present in low levels (usually less than 1%) in most cannabis strains, CBG is considered a minor cannabinoid, but a major pain reliever.

testimonial Stephen Daytona Beach, FL

Stephen interviewed 10 mins later post CBD

Ultra Premium CBG & CBD Full Spectrum Hemp Oil Sublingual

Our Phytocannabinoid-Rich (PCR) Tincture products are created with hemp seed oil

and grape seed oil, and infused with our Pure Hemp Oil (60-80% CBD, 0% THC).



CBG is the chemical parent of  THC and CBD   both of which start out as CBG—it’s the chemical parent of THC and CBD. Cannabis plants produce cannabigerolic acid (CBGA), the precursor to the three main cannabinoid lines: Tetrahydrocannabinolic acid (THCA), Cannabidiolic acid (CBDA), and Cannabichromenic acid (CBCA).

Specific enzymes in the plant break CBGA down and “direct” it toward one of the three lines. The acids are exposed to ultraviolet light or heat, then become  THC, CBD, etc. In most strains, CBGA is immediately converted to either THCA or CBDA. Thus, more THC means less CBG and CBD (and vice versa) by nature of how these compounds are synthesized.

To obtain higher yields of CBG, breeders are experimenting with genetic manipulation and cross-breeding of plants. For example, Subcool Seeds is crossing strains to produce higher CBG contents. Scientists can also extract higher levels of CBG from budding plants by pinpointing the optimum extraction time, about six weeks into an eight week flowering cycle. A medicinal strain called  Bediol is produced in this fashion by the Dutch company Bedrocan BV Medicinal Cannabis.

So lets try and simplify this

We do know that CBG counteracts the effects of THC and that CBG is a CB1-receptor antagonist, which means it directly affects the human nervous system. CBG is thought to inhibit the uptake of GABA in the brain, which in turn is thought to decrease general anxiety as well as muscle tension.

A number of studies have been carried out demonstrating that CBG could treat a whole host of medical conditions including inflammation, inflammatory bowel disease, glaucoma, and even certain types of cancer.

A study carried out in Italy, published back in May 2013 in the Biological Psychology publication, found that just like CBD, CBG has also strong anti-inflammatory properties and helped many patients.

CBG is thought to be a great pain reliever, due to its analgesic effects, for conditions such as Multiple Sclerosis (MS) and pain caused by some forms of cancer, as well as many soft tissue conditions.

According to the research, CBG has the ability to reduce inflammation by targeting the specific molecules responsible for inflammation. This includes soft tissue tension and inflammation, as well as inflammation associated with bowel disease.

In a study published in August 2016, called “Phytocannabinoids for use in the treatment of intestinal inflammatory diseases” researchers found that CBG could help patients with various inflammation issues, as well as Colitis and Crohn’s disease.

Many people who suffer from anxiety, either general or specific, use a host of psychotropic drugs to be able to handle everyday life. But there’s good news; A Study from 2016 carried out by Ethan B. Russo, suggests that CBG has a similar calming effect to THC but without the sometimes confusing high. As it is mainly non-psychoactive, CBG could be the future for treating anxiety.

We need do alot more research. However, we are definitely going in the correct direction. Maybe some day Opiod Abuse and Addiction can be eradicated via the use of CBG.